LINCOMYCIN IN DERMATOLOGIC PRACTICE.
In clinical studies with a new oral antibiotic, lincomycin, excellent results were obtained in the treatment of carbuncles, furuncles, folliculitis, cellulitis, lymphangitis, lymphadenitis, pyonychias and dermatitis infectiosa eczematoides due to coagulase-positive Staphylococcus aureus and to Streptococcus hemolyticus Type A. Encouraging results were noted in a small series of acne conglobata (cystic acne). Loose stools and diarrhea were frequently encountered but these symptoms abated when the dosage was reduced.
D000152:Acne Vulgaris; D000293:Adolescent; D000818:Animals; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002481:Cellulitis; D003967:Diarrhea; D004358:Drug Therapy; D005667:Furunculosis; D006801:Humans; D008034:Lincomycin; D012871:Skin Diseases; D012874:Skin Diseases, Infectious; D013203:Staphylococcal Infections; D013210:Staphylococcus; D013211:Staphylococcus aureus; D013290:Streptococcal Infections; D014116:Toxicology
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D008034:Lincomycin
ACNE; ADOLESCENCE; ANTIBIOTICS; DIARRHEA; DRUG THERAPY; LINCOMYCIN; SKIN DISEASES; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TOXICOLOGIC REPORT